Omicron-specific vaccine boosters get FDA sign-off
by Nicole Wetsman from The Verge - All Posts on (#633MT)
Illustration by Alex Castro / The Verge COVID-19 vaccines designed to target the omicron variant have just been authorized by the Food and Drug Administration. Both Pfizer / BioNTech and Moderna got the FDA's sign-off for their booster doses of the reformulated shot. This is the first update to COVID-19 vaccines to be authorized in the United States.
The Pfizer / BioNTech booster is available to people 12 and older, and the Moderna shot will be available to people 18 and older. They'll only be boosters - they can't be used by people who haven't already had their first doses.
The new booster shots target both the original strain of the coronavirus and the BA.4 and BA.5 lineages of the omicron variant - which are currently the predominant versions of the virus in circulation.
T...